Haemonetics (HAE) Tops Q3 EPS by 15c, Revenues Beat
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $107.60 +1.28%
EPS Growth %: 0.0%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: 0.0%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $0.81, $0.15 better than the analyst estimate of $0.66. Revenue for the quarter came in at $240 million versus the consensus estimate of $225.73 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades Haemonetics to Buy, raises price target to $123
- TotalEnergies strikes $1.8B deal with GIP on African assets
- Astrana Health (ASTH) Mentioned as short at Glass House
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
